Trials / Enrolling By Invitation
Enrolling By InvitationNCT06435494
Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions
C-PRO - The Effect of Cross-sectorial Use of Patient-Reported Outcomes for Patients With Chronic Degenerative Shoulder Conditions
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
This research project aims to test if systematic (extensive) use of patient-reported outcomes across treatment boundaries can 1. improve patients' and health professionals' understanding of individual patients' conditions and health changes, 2. improve indications for treatment, 3. strengthen patient empowerment, and 4. reduce patients' utilization of health services. The study will be performed in the particular context of patients with chronic degenerative conditions of the shoulder. These patients are characterized by contact with numerous health professionals from different health sectors, such as general practitioner, physiotherapists and surgical referral centres, which challenges coherence and communication for the individual treatment decisions. The research project will be performed as a randomized controlled trial (RCT) with a 1-year inclusion period and two years of follow-up.
Conditions
- Shoulder Disease
- Shoulder Impingement
- Shoulder Osteoarthritis
- Shoulder Frozen
- Shoulder Capsulitis
- Shoulder Bursitis
- Shoulder Impingement Syndrome
- Rotator Cuff Syndrome
- Rotator Cuff Syndrome of Shoulder and Allied Disorders
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Systematic use of patient reported outcome measures in clinical work with the patients | Se description of the arms |
Timeline
- Start date
- 2024-08-12
- Primary completion
- 2030-09-01
- Completion
- 2030-09-01
- First posted
- 2024-05-30
- Last updated
- 2025-04-02
Locations
6 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06435494. Inclusion in this directory is not an endorsement.